Does TOVORAFENIB Cause Intracranial tumour haemorrhage? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Intracranial tumour haemorrhage have been filed in association with TOVORAFENIB (OJEMDA). This represents 4.0% of all adverse event reports for TOVORAFENIB.
8
Reports of Intracranial tumour haemorrhage with TOVORAFENIB
4.0%
of all TOVORAFENIB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Intracranial tumour haemorrhage From TOVORAFENIB?
Of the 8 reports, 2 (25.0%) required hospitalization.
Is Intracranial tumour haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOVORAFENIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TOVORAFENIB Cause?
Accidental underdose (19)
Disease progression (16)
Rash (16)
Fatigue (15)
Off label use (13)
Headache (12)
Hair colour changes (11)
Blood creatine phosphokinase increased (10)
Acne (8)
Dermatitis acneiform (7)
What Other Drugs Cause Intracranial tumour haemorrhage?
NIVOLUMAB (35)
BEVACIZUMAB (33)
TEMOZOLOMIDE (26)
IPILIMUMAB (23)
APIXABAN (13)
AZACITIDINE (12)
CYCLOPHOSPHAMIDE (12)
ALEMTUZUMAB (11)
ASPIRIN (11)
BINIMETINIB (11)
Which TOVORAFENIB Alternatives Have Lower Intracranial tumour haemorrhage Risk?
TOVORAFENIB vs TOZINAMERAN
TOVORAFENIB vs TRABECTEDIN
TOVORAFENIB vs TRACLEER
TOVORAFENIB vs TRADJENTA
TOVORAFENIB vs TRALOKINUMAB-LDRM